RHN van Schaik

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for <i>CYP3A5</i> Genotype and Tacrolimus Dosing

Brian S. Decker, JM Barbarino, JF Peterson et al. · Clinical Pharmacology & Therapeutics · 2015 · 692 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Genetic Variation in the CYP2D6 Gene Is Associated With a Lower Heart Rate and Blood Pressure in β-Blocker Users

M. Bijl, LE Visser, RHN van Schaik et al. · Clinical Pharmacology & Therapeutics · 2008 · 145 citations

Medicine, Cardiology, Pharmacology +16

Cytochrome P450 2C9 *2 and *3 Polymorphisms and the Dose and Effect of Sulfonylurea in Type II Diabetes Mellitus

LE Visser, P. Trienekens, Albert Hofman et al. · Clinical Pharmacology & Therapeutics · 2007 · 118 citations

Medicine, Endocrinology, Pharmacology +16

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

Kelly A. Birdwell, Brian S. Decker, Julia M. Barbarino et al. · Data Archiving and Networked Services (DANS) · 2015 · 88 citations

Medicine, Pharmacokinetics, Pharmacology +16

The 5-HT1A receptor C(1019)G polymorphism influences the intravaginal ejaculation latency time in Dutch Caucasian men with lifelong premature ejaculation

Paddy K.C. Janssen, RHN van Schaik, Aeilko H. Zwinderman et al. · Pharmacology Biochemistry and Behavior · 2014 · 51 citations

Medicine, Genetics, Urology +17